Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Cervical Cancer

  Free Subscription


23.02.2026

1 Abdom Radiol (NY)
1 ACS Omega
1 Acta Obstet Gynecol Scand
1 Adv Mater
2 Afr J Reprod Health
1 Am J Obstet Gynecol
1 Arch Microbiol
1 Biomark Med
2 BMC Cancer
1 BMC Health Serv Res
2 BMC Public Health
2 BMC Womens Health
1 BMJ Open
1 Bull Cancer
1 Cancer Rep (Hoboken)
1 Community Health Equity Res Policy
1 Crit Rev Immunol
2 Discov Oncol
1 Endocr Metab Immune Disord Drug Targets
1 Ethn Health
1 Eur J Med Res
1 Eur J Public Health
1 Front Cell Infect Microbiol
2 Front Oncol
1 Front Public Health
1 Gynecol Oncol
1 Immunol Lett
2 Int J Gynecol Cancer
1 Int J Radiat Oncol Biol Phys
2 J Am Board Fam Med
1 J Appl Clin Med Phys
1 J Clin Oncol
1 J Clin Pathol
1 J Family Community Med
1 J Health Psychol
1 J Infect Dis
3 J Med Screen
1 J Med Virol
1 J Mol Histol
1 JCO Glob Oncol
1 Lakartidningen
1 Lancet
1 Med Oncol
1 Mol Cancer
1 Nat Commun
1 Physiol Meas
2 PLoS One
1 Proc Inst Mech Eng H
1 Radiother Oncol
2 Sci Rep
1 Tech Innov Patient Support Radiat Oncol
1 Vaccine
1 Womens Health (Lond)


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Abdom Radiol (NY)

  1. WANG B, Xiao J, Ding Y, Yu J, et al
    Preoperative prediction of parametrial invasion in early-stage cervical cancer: a radiomics nomogram fusing multi-parametric MRI and clinical biomarkers.
    Abdom Radiol (NY). 2026 Feb 16. doi: 10.1007/s00261-025-05353.
    PubMed         Abstract available


    ACS Omega

  2. WANG Z, Zhang Y, Xiu Y, Chen Z, et al
    Au-PtNPs@Mn(3)O(4) Nanozymes Enhance the Antitumor Effect of Photodynamic Therapy and Radiotherapy in Cervical Cancer by Modulating Tumor Hypoxia.
    ACS Omega. 2026;11:8183-8196.
    PubMed         Abstract available


    Acta Obstet Gynecol Scand

  3. KALLIALA I, Milerad H, Trope AEC, Hammer A, et al
    Why do the Nordic countries allow colposcopy to be a weak link in the cervical cancer screening chain?
    Acta Obstet Gynecol Scand. 2026 Feb 17. doi: 10.1111/aogs.70166.
    PubMed        


    Adv Mater

  4. XIA D, Gao Z, Li J, Chen C, et al
    pH-Responsive Biomineralized Probiotic for Self-Amplifying Mucosal Vaccination: Gut-Engineered Antigen Factories Drive Targeted Cervical Tumor Regression.
    Adv Mater. 2026;38:e10404.
    PubMed         Abstract available


    Afr J Reprod Health

  5. LI D
    Influence of gemcitabine combined with lobaplatin interventional embolization on vaginal flora and biofilm formation in patients with advanced cervical cancer.
    Afr J Reprod Health. 2026;30:38-50.
    PubMed         Abstract available

  6. KIBONIRE RA, Mphuthi DD
    Understanding the determinants of cervical cancer screening uptake in Hoima District, Uganda.
    Afr J Reprod Health. 2026;30:104-113.
    PubMed         Abstract available


    Am J Obstet Gynecol

  7. AGUSTI N, Viveros-Carreno D, Wu CF, Iniesta MD, et al
    Survival Outcomes After Inadvertent Surgery in Low-Risk Early-Stage Cervical Cancer.
    Am J Obstet Gynecol. 2026 Feb 16:S0002-9378(26)00081.
    PubMed         Abstract available


    Arch Microbiol

  8. SINGH A, Sahani P, Singh S, Ojha A, et al
    Role of human papillomavirus (HPV) variants and host genetic susceptibility in cervical carcinogenesis.
    Arch Microbiol. 2026;208:198.
    PubMed         Abstract available


    Biomark Med

  9. ZHONG M, Peitz J, Newman M, Yussuf S, et al
    Novel circRNA signatures in cervical cancer: implications for early detection and screening.
    Biomark Med. 2026 Feb 19:1-10. doi: 10.1080/17520363.2026.2631965.
    PubMed         Abstract available


    BMC Cancer

  10. ANENA S, Okello MO, Ouma RC, Olum R, et al
    Uptake of cervical cancer screening services among women of reproductive age enrolled in HIV care: a facility-based cross-sectional study in rural Northern Uganda.
    BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15708.
    PubMed        

  11. WANGUSI R, Ngugi E, Wafula S, Awuor P, et al
    Enhancing cervical cancer screening uptake through self-sampling for HPV DNA testing: insights and results from implementing in routine HIV clinics serving women living with HIV in Nairobi, Kenya, 2021-2024.
    BMC Cancer. 2026 Feb 21. doi: 10.1186/s12885-026-15771.
    PubMed        


    BMC Health Serv Res

  12. CHIGBU CO, Dim CC, Eneh SC, Olakunde BO, et al
    Cervical cancer screen-and-treat services at HIV treatment sites in Nigeria: findings from the ICON-3 Practice Based Research Network.
    BMC Health Serv Res. 2026 Feb 20. doi: 10.1186/s12913-026-14167.
    PubMed        


    BMC Public Health

  13. ZHAO X, Huang Y, Lv Q, Wang L, et al
    Awareness of cervical cancer and its correlates among junior high school students in Eastern China: a cross sectional study.
    BMC Public Health. 2026 Feb 20. doi: 10.1186/s12889-026-26748.
    PubMed        

  14. ANAND KV, Mishra GA, Suryawanshi VB, Pimple SA, et al
    Experiences with HPV self-sampling in India: advancing cervical cancer prevention and screening.
    BMC Public Health. 2026 Feb 19. doi: 10.1186/s12889-026-26212.
    PubMed        


    BMC Womens Health

  15. ZHANG X, Wang J, Ke G, Zhang Y, et al
    Self-management experiences of vaginal toxicities among patients undergoing radical radiotherapy for cervical cancer: a qualitative study.
    BMC Womens Health. 2026 Feb 21. doi: 10.1186/s12905-026-04343.
    PubMed        

  16. LAMICHHANE A, Kaphle HP, Neupane N, Baral S, et al
    Factors associated with cervical cancer screening uptake among women aged 30-49 years of Bhanu Municipality, Tanahun, Nepal: a cross-sectional study.
    BMC Womens Health. 2026 Feb 21. doi: 10.1186/s12905-026-04360.
    PubMed        


    BMJ Open

  17. AMUBUOMOMBE PP, Itsura P, Tonui PK, Orang'o EO, et al
    Pregnancy outcomes among women with and without HIV infections who underwent excisional treatment for high-grade cervical intraepithelial neoplasia: a retrospective cohort study in low-resource settings.
    BMJ Open. 2026;16:e105559.
    PubMed         Abstract available


    Bull Cancer

  18. LAAS E, Gaillard T, Fourchotte V, Hotton J, et al
    [Cervical cancer with SHAPE criteria: Conisation before simple hysterectomy].
    Bull Cancer. 2026 Feb 19:S0007-4551(26)00101.
    PubMed        


    Cancer Rep (Hoboken)

  19. MUNE G, Asefa A, Chillo SL, Woldesemayat EM, et al
    Cervical Cancer Screening and Associated Factors Among Women of Reproductive Age in Sidama Regional State of Ethiopia: A Cross-Sectional Survey.
    Cancer Rep (Hoboken). 2026;9:e70498.
    PubMed         Abstract available


    Community Health Equity Res Policy

  20. VEERAVAGU T, Hamdiui N, Stein ML, Al-Rubaie N, et al
    Supporting Informed Decision-Making Regarding Participation in Cervical Cancer Prevention Programs: A Qualitative Study Among Turkish-, Moroccan-, and Syrian-Dutch Women.
    Community Health Equity Res Policy. 2026 Feb 20:2752535X261427045.
    PubMed         Abstract available


    Crit Rev Immunol

  21. LIN J, Lin M, Lin L, Chen Q, et al
    Single-Cell Sequencing Combined with RNA Sequencing Reveals the Role of Natural Killer Cells in Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma.
    Crit Rev Immunol. 2026;46:27-43.
    PubMed         Abstract available


    Discov Oncol

  22. ZHANG X, Tao X, Bao K
    Comparative analysis of trends and projections of cervical cancer burden among women aged 20-64 years in China, Japan, and South Korea, 1990-2050.
    Discov Oncol. 2026 Feb 18. doi: 10.1007/s12672-026-04688.
    PubMed         Abstract available

  23. YANG Q, Zhao J, Liu X, Liu J, et al
    Identification and mechanistic exploration of VEGFA and CALML3 as calcium channel-related prognostic genes in cervical cancer.
    Discov Oncol. 2026 Feb 16. doi: 10.1007/s12672-026-04683.
    PubMed        


    Endocr Metab Immune Disord Drug Targets

  24. KANG M, Jiang S, Chen H, Xu Y, et al
    Prediction of the Prognosis and Treatment Responses Based on the Characteristics of Disulfidptosis-Related Genes in Patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Endocr Metab Immune Disord Drug Targets. 2026;26:e18715303374396.
    PubMed         Abstract available


    Ethn Health

  25. OGUNDARE OC, Adeyemo GO, Folorunsho S
    Determinants of cervical cancer screening among African and African American women: a qualitative systematic review.
    Ethn Health. 2026 Feb 17:1-16. doi: 10.1080/13557858.2026.2630820.
    PubMed         Abstract available


    Eur J Med Res

  26. CHEN J, Mo Z, Pan J, Jia L, et al
    Automated gross tumour volume delineation on T2-weighted magnetic resonance imaging coupled with radiomics for predicting cervical cancer recurrence.
    Eur J Med Res. 2026 Feb 18. doi: 10.1186/s40001-025-03777.
    PubMed         Abstract available


    Eur J Public Health

  27. KOIVISTO T, Kalliala I, Eriksson T, Nieminen P, et al
    Human papillomavirus vaccinations' impact on preterm birth rates.
    Eur J Public Health. 2026;36:214-219.
    PubMed         Abstract available


    Front Cell Infect Microbiol

  28. WANG X, Xiong D, Duan B, Huang Y, et al
    Mechanistic pathways predictive modeling and translational interventions for radiation enteritis in cervical cancer radiotherapy.
    Front Cell Infect Microbiol. 2026;15:1729528.
    PubMed         Abstract available


    Front Oncol

  29. CHENG X, Wang J, Wang H, Song H, et al
    Case Report: A rare case of external iliac artery rupture and sigmoid fistula following multimodal treatment for cervical cancer.
    Front Oncol. 2026;16:1708443.
    PubMed         Abstract available

  30. GOMES P, de Abreu WC, Dos Reis RG, Guerra ENS, et al
    Photobiomodulation therapy approach to a rare phenomenon of radiation recall reaction triggered by cisplatin in a cervical cancer patient: a case report and scoping review.
    Front Oncol. 2026;15:1700942.
    PubMed         Abstract available


    Front Public Health

  31. THARAVICHITKUL E, Chitapanarux I, Sripan P, Tovanabutra C, et al
    Unlocking economic gains: the impact of image-guided brachytherapy on cervical cancer treatment in Thailand.
    Front Public Health. 2026;13:1725415.
    PubMed         Abstract available


    Gynecol Oncol

  32. DAIX-MOREUX M, El Hajj H, Scherier S, Deandreis D, et al
    Para-aortic lymphadenectomy after negative PET-CT in locally advanced cervical cancer: a continuous monocentric series of 320 cases.
    Gynecol Oncol. 2026;206:99-105.
    PubMed         Abstract available


    Immunol Lett

  33. RICARDO MG, Alberto MG, Maria HA, Ramos, et al
    PD-L1 expression in cervical cancer tissue is strongly associated with the expression of CD73/TGF-beta1, the percentage of CD8+/PD-1+ T cells and disease progression.
    Immunol Lett. 2026 Feb 16:107150. doi: 10.1016/j.imlet.2026.107150.
    PubMed         Abstract available


    Int J Gynecol Cancer

  34. WANG L, Wei Y, Wu Q
    Correspondence on "Identifying possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer" by Matsuo et al.
    Int J Gynecol Cancer. 2025;35:102710.
    PubMed        

  35. EBRAHIMOGHLI R, Agaei MH, Hakimi MH, Moradoghli F, et al
    Temporal trends and sources of variation in late-stage cervical cancer diagnosis in low- and middle-income countries: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2026 Jan 28:104479. doi: 10.1016/j.ijgc.2026.104479.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  36. SMITH EE, Heintz JR, Chesnokova A, Taunk NK, et al
    Improving treatment of radiation-induced premature ovarian insufficiency after cervical cancer: A practice quality improvement initiative.
    Int J Radiat Oncol Biol Phys. 2026 Feb 14:S0360-3016(26)00389.
    PubMed         Abstract available


    J Am Board Fam Med

  37. YOUNG AP, O'Dwyer MC, Smith R, Saunders N, et al
    Kennedy v Braidwood Ruling Affects Women and Cervical Cancer Screening.
    J Am Board Fam Med. 2025;38:1113-1116.
    PubMed         Abstract available

  38. SOLTANI LF, Addis I, Lin P, Kamdar N, et al
    Characterizing Cervical Cancer Screening in the US: Preparing for the Era of Self-Collection.
    J Am Board Fam Med. 2026 Feb 16. doi: 10.3122/jabfm.2025.250040.
    PubMed         Abstract available


    J Appl Clin Med Phys

  39. MENG X, Wang Z, Zhang Y, Wang X, et al
    RapidArc Dynamic (RAD) multi-mechanical axis optimization achieves enhanced OAR sparing in cervical cancer: A dosimetric comparison study.
    J Appl Clin Med Phys. 2026;27:e70506.
    PubMed         Abstract available


    J Clin Oncol

  40. WENTZENSEN N, Egemen D, Clarke MA, Poitras N, et al
    Long-Term Prospective Cohort Study of Cervical Cancer Screening Using Triage of Women who Are Human Papillomavirus-Positive With Dual Stain and Human Papillomavirus Genotyping.
    J Clin Oncol. 2026 Feb 17:JCO2500689. doi: 10.1200/JCO-25-00689.
    PubMed         Abstract available


    J Clin Pathol

  41. CUSCHIERI K, Latsuzbaia A, McMahon H, Giubbi C, et al
    Clinical performance assessment of the Papilloplex HR-HPV assay on self-taken urine and vaginal swab samples: findings from a multicentre European study.
    J Clin Pathol. 2025 Nov 7:jcp-2025-210211. doi: 10.1136/jcp-2025-210211.
    PubMed         Abstract available


    J Family Community Med

  42. RAY S, Nagar A
    Educational intervention and its effect on medical students' knowledge and readiness for cervical cancer screening and human papillomavirus vaccination.
    J Family Community Med. 2026;33:53-54.
    PubMed        


    J Health Psychol

  43. GAO J, Yang R, Lu R, Ma X, et al
    Current status and influencing factors of different dimensions of HPV knowledge among HPV-infected women.
    J Health Psychol. 2026;31:536-549.
    PubMed         Abstract available


    J Infect Dis

  44. MUKEREBE C, Cordeiro AA, Aristide C, Colombe S, et al
    Schistosome Infection is Associated with High-Risk Human Papillomavirus Persistence, Together with Altered Cervicovaginal Microbiota.
    J Infect Dis. 2025 Aug 22:jiaf447. doi: 10.1093.
    PubMed         Abstract available


    J Med Screen

  45. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Ripple effect of temporary self-sampling HPV test on screening uptake in the next round: A secondary analysis of the ACCESS randomized controlled trial.
    J Med Screen. 2026;33:62-65.
    PubMed         Abstract available

  46. FITZPATRICK P, O'Flynn A, Jalal R, Frazer K, et al
    Identifying barriers and facilitators to participation in cancer screening among Irish travellers, a minority ethnic group in Ireland, using a codesigned approach.
    J Med Screen. 2026;33:9-14.
    PubMed         Abstract available

  47. CULLIMORE V, Newhouse R, Baker-Rand H, Chu K, et al
    Investigating the acceptability of cervical screening, using conventional clinician-taken cervical samples or urine self-sampling, at 6 weeks postnatal: A cross-sectional questionnaire.
    J Med Screen. 2026;33:48-58.
    PubMed         Abstract available


    J Med Virol

  48. LIU Y, Wang S, Gao S
    Human Papillomavirus (HPV) Type Distribution in Cervical Carcinoma, Low-Grade, and High-Grade Squamous Intraepithelial Lesions in Women Under 25 Years Old From the Largest Women Hospital in China.
    J Med Virol. 2026;98:e70846.
    PubMed         Abstract available


    J Mol Histol

  49. LI Y, Wang F, Fang Z, Sun H, et al
    MUL1 suppresses cervical cancer progression by targeting FUNDC1 for ubiquitination and inhibiting DRP1-dependent mitophagy.
    J Mol Histol. 2026;57:79.
    PubMed         Abstract available


    JCO Glob Oncol

  50. VIDAURRE MENDES S, Kischinhevsky DG, Lopes da Silva J, Dos Santos ALS, et al
    Epidemiology of Cervical Cancer in Brazil: Age-Specific Trends From 2000 to 2018.
    JCO Glob Oncol. 2026;12:e2500416.
    PubMed         Abstract available


    Lakartidningen

  51. MILERAD H, Bonander C, Nordqvist Kleppe S, Dillner J, et al
    [Geomapping of 10-year coverage rate of cervical cancer screening in Sweden - a basis for targeting population-level interventions to improve screening].
    Lakartidningen. 2026;123:25052.
    PubMed         Abstract available


    Lancet

  52. LEJEUNE CL, Van Calsteren K, Baert T, Vandecaveye V, et al
    A multidisciplinary management approach to cervical cancer during pregnancy.
    Lancet. 2026 Feb 17:S0140-6736(26)00190-X. doi: 10.1016/S0140-6736(26)00190.
    PubMed        


    Med Oncol

  53. ALMASABI SHA, Almasoudi HH, Albargy H, Alabbas MMA, et al
    Retraction Note: Alternative use of Droxidopa for treating cervical cancer: inhibiting transferase, cell cycle signalling, and transport proteins via multitarget docking, DFT, MD simulations, and binding free energy studies.
    Med Oncol. 2026;43:150.
    PubMed        


    Mol Cancer

  54. WANG Z, Wang Z, Jiang J, Yang L, et al
    Reprogramming the tumor immune microenvironment in cervical cancer: synergy between radiotherapy and immunotherapy.
    Mol Cancer. 2026 Feb 17. doi: 10.1186/s12943-026-02600.
    PubMed        


    Nat Commun

  55. CHEN Q, Quan J, Zhu K, Lan L, et al
    Variations in the Natural History of High-Risk HPV Types Following HPV-16/18 Bivalent Vaccination in Females Aged 18-45 Years.
    Nat Commun. 2026;17:1677.
    PubMed         Abstract available


    Physiol Meas

  56. ZHANG T, Choon Park D, Jeong Jeong Y, Geun Yeo S, et al
    Screening of cervical intraepithelial neoplasia based on multiple features extracted from multi-electrode bioimpedance spectroscopy.
    Physiol Meas. 2026;47.
    PubMed         Abstract available


    PLoS One

  57. HADDADI M, Golestani A, Farzi Y, Rezaei N, et al
    Iran is falling behind WHO cervical cancer elimination targets: HPV vaccination coverage and cervical cancer screening participation in 2021.
    PLoS One. 2026;21:e0341888.
    PubMed         Abstract available

  58. KIM WJ, Kim YW
    Association between cervical conization and pregnancy outcomes: A nationwide population-based cohort study.
    PLoS One. 2026;21:e0341660.
    PubMed         Abstract available


    Proc Inst Mech Eng H

  59. ZOU R, Xu J, Fang Q, Guan R, et al
    A novel cervical image recognition framework based on feature cognitive enhancement for improved performance.
    Proc Inst Mech Eng H. 2026;240:192-205.
    PubMed         Abstract available


    Radiother Oncol

  60. CORBEAU A, Spampinato S, Charnalia M, Ranjan N, et al
    Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial.
    Radiother Oncol. 2026;218:111444.
    PubMed         Abstract available


    Sci Rep

  61. LI X, Sun L, Qiu M, Wu X, et al
    Investigation of thoracico-abdominal infrared thermal imaging characteristics in patients with cervical HR-HPV infection.
    Sci Rep. 2026;16:6500.
    PubMed         Abstract available

  62. POPOVIC J, Hahut A, Torres GE, Vincent A, et al
    Changes in EGFR activity following CRISPR/Cas9-editing of the EGF binding domain.
    Sci Rep. 2026;16:6797.
    PubMed         Abstract available


    Tech Innov Patient Support Radiat Oncol

  63. YORKE AA, Muramuzi A, Lin LL, Awusa K, et al
    Quantifying cervical cancer radiotherapy care gap: Baseline assessment prior to implementation of a digital Health App.
    Tech Innov Patient Support Radiat Oncol. 2026;37:100381.
    PubMed         Abstract available


    Vaccine

  64. STUART R, Theopold N, Miall N, Kobayashi E, et al
    The role of HPV single-dose vaccination in expanding access in GAVI-supported countries during a period of supply constraints.
    Vaccine. 2026;75:128187.
    PubMed         Abstract available


    Womens Health (Lond)

  65. ROWLINSON E, Snih SA
    Factors associated with mammogram and Papanicolaou testing among Mexican American older women.
    Womens Health (Lond). 2026;22:17455057261421727.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum